Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro

References

• Äbelö A, Andersson TB, Antonsson M, Naudot AK, Skånberg I, Weidolf L. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Drug Metabolism and Disposition 2000; 8: 966–972
   Google Scholar
• Aitio A. A simple and sensitive assay of 7-hydroxycoumarin deethylation. Annals of Biochemistry 1978; 5: 488–491
   Web of Science ®Google Scholar
• Anzenbacherova E, Anzenbacher P, Svoboda Z, Ulrichova J, Kvetina J, Zoulova J, Perlik F, Martinkova J. Minipeg as a model for drug metabolism in man: Comparison of in vitro and in vivo metabolism of propafenone. Medical Papers 2003; 147: 155–159
   Google Scholar
• Anzenbacher P, Soucek P, Anzenbacherova E, Gut I, Hruby K, Svoboda Z, Kvetina J. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metabolism and Disposition 1998; 6: 56–59
   Google Scholar
• Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, Van Bladeren PJ, Walther B. Determining the best animal model for human cytochrome P450 activities: A comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000; 30: 1131–1152
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Burke MD, Prough RA, Mayer RT. Characteristics of a microsomal cytochrome P-448-mediated reaction ethoxyresorufin O-deethylation. Drug Metabolism and Disposition 1977; 5: 1–8
   PubMed Web of Science ®Google Scholar
• Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metabolism and Disposition 1997; 5: 1130–1136
   Google Scholar
• Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metabolism and Disposition 2000; 8: 1222–1230
   Google Scholar
• Gonzalez FJ. Transgenic models in xenobiotic metabolism and toxicology. Toxicology 2002; 7: 237–239
   Web of Science ®Google Scholar
• Graham MJ, Bell AR, Crewe HK, Moorcraft CL, Walker L, Whittaker EF, Lennard MS. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. Xenobiotica 2003; 3: 225–237
   Web of Science ®Google Scholar
• Greenlee WF, Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Pharmacology and Experimental Therapy 1978; 205: 596–605
   PubMed Web of Science ®Google Scholar
• Hesse LM, Venkatakrishnan K, Court MH, Von Moltke LL, Duan SX, Shader RI, Greenblatt DJ. CYP2B6 mediates the in vitro hydroxylation of bupropion: Potential drug interactions with other antidepressants. Drug Metabolism and Disposition 2000; 8: 1176–1183
   Google Scholar
• Knodell RG, Hall SD, Wilkinson GR, Guengerich FP. Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. Journal of Pharmacology and Experimental Therapy 1987; 41: 1112–1119
   Google Scholar
• Kronbach T, Mathys D, Gut J, Catin T, Meyer UA. High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Annals of Biochemistry 1987; 62: 24–32
   Web of Science ®Google Scholar
• Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Molecular Pharmacology 1989; 6: 89–96
   Google Scholar
• Lewis DF. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: A compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families. Current Medicine and Chemistry 2003; 10: 1955–1972
   PubMed Web of Science ®Google Scholar
• Lewis DF, Lake BG. Species differences in coumarin metabolism: A molecular modelling evaluation of CYP2A interactions. Xenobiotica 2002; 2: 547–561
   Web of Science ®Google Scholar
• Lisitsa A, Archakov A, Lewi P, Janssen P. Bioinformatic insight into the unity and diversity of cytochromes P450. Methods and Finds in Experimental and Clinical Pharmacology 2003; 5: 733–745
   Google Scholar
• Park YH, Kullberg MP, Hinsvark ON. Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography. Journal of Pharmacology Science 1984; 73: 24–29
   PubMed Web of Science ®Google Scholar
• Pasanen M. Species differences in CYP enzymes. Citocromo P450, MC Angosto, MJ Gomez-Lechon. Instituto De Espana, Real Academia Nacional De Farmacia Madrid, Madrid 2004; 3–90
   Google Scholar
• Pelkonen O. Human CYPs: in vivo and clinical aspects. Drug Metabolism Reviews 2002; 34: 37–46
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Kaltiala EH, Larmi TKI, Karki NT. Cytochrome P450-linked monooxygenase system and drug-induced spectral interactions in human liver microsomes. Chemico-Biological Interactions 1974; 9: 205–216
   PubMed Web of Science ®Google Scholar
• Peter R, Böcker R, Beaune PH, Iwasaki M, Guengerich FP, Chung SY. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chemical Research in Toxicology 1990; 3: 566–573
   PubMed Web of Science ®Google Scholar
• Peters-Volleberg GWM, De Waal EJ, Van der Laan JW. Interspecies extrapolation in safety evaluation of human medicines in The Netherlands. 1990–1992): Practical considerations. Regulatory Toxicology and Pharmacology 1994; 20: 248–258
   PubMed Web of Science ®Google Scholar
• Raunio H, Syngelma T, Pasanen M, Juvonen R, Honkakoski P, Kairaluoma MA, Sotaniemi E, Lang MA, Pelkonen O. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochemistry and Pharmacology 1988; 37: 3889–3895
   PubMed Web of Science ®Google Scholar
• Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN, Wrighton SA. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition 1995; 23: 1231–1241
   PubMed Web of Science ®Google Scholar
• Shimada T, Mimura M, Inoue K, Nakamura S, Oda H, Ohmori S, Yamazaki H. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Archives in Toxicology 1997; 71: 401–408
   PubMed Web of Science ®Google Scholar
• Skaanild MT, Friis C. Characterization of the P450 system in Gottingen minipigs. Pharmacology and Toxicology 1997; 80: 28–33
   PubMedGoogle Scholar
• Suckow RF, Smith TM, Perumal AS, Cooper TB. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. Drug Metabolism and Disposition 1986; 14: 692–697
   PubMed Web of Science ®Google Scholar
• Sullivan-Klose TH, Ghanayem BI, Bell DA, Zhang Z-Y, Kaminsky LS, Shenfield GM, Miners JO, Birkett DJ, Goldstein JS. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics 1996; 6: 341–349
   PubMedGoogle Scholar
• Taavitsainen P, Juvonen R, Pelkonen O. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metabolism and Disposition 2001; 29: 217–222
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O. Selective inhibition of CYP2B6-catalysed bupropion hydroxylation in human liver microsomes in vitro. Drug Metabolism and Disposition 2004; 32: 626–631
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Uusitalo J, Jalonen J, Pelkonen O. Multiple P450 substrates in a single run: Rapid and comprehensive in vitro interaction assay. European Journal of Pharmacology Science 2005; 24: 123–132
   PubMed Web of Science ®Google Scholar
• Voisin EM, Ruthsatz, Collins JM, Hoyle PC. Extrapolation of animal toxicity to humans: Interpecies comparisons in drug development. Regulatory Toxicology and Pharmacology 1990; 12: 107–116
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Chang TK. Use of 7-ethoxycoumarin to monitor multiple enzymes in the human CYP1, CYP2, and CYP3 families. Methods in Molecular Biology 1998; 107: 175–179
   PubMedGoogle Scholar
• Zuber R, Anzenbacherova E, Anzenbacher P. Cytotochromes P450 and experimental models of drug metabolism. Journal of Cellular and Molecular Medicine 2002; 6: 189–198
   PubMed Web of Science ®Google Scholar